Press Releases
Johnson & Johnson Completes Acquisition of Micrus Endovascular
Johnson & Johnson announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke.  Johnson & Johnson announced its agreement to acquire Micrus on July 12,...
Press Releases
BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
AstraZeneca announced today that the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on the marketing authorisation application for BRILIQUEâ„¢ (ticagrelor) for the prevention of atherothrombotic events in adult patients with Acute Coronary Syndromes (ACS)....
Press Releases
FLUOstar Omega Named Drug Discovery Product of the Year 2010
 BMG LABTECH is proud to announce that the FLUOstar Omega multimode microplate reader has received the award for 'Drug Discovery Product of the Year 2010'. This is a special honour as it is an independent users'...
Press Releases
Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology in Appetite Suppression Study
Emisphere Technologies, Inc. announced that a clinical study found that the company's proprietary oral SNAC (Sodium N- Caprylate ("SNAC") additive, in combination with two digestive hormones, was successful in reducing food intake and increasing satiety in healthy male subjects....
Press Releases
Out Now: Rotronic Humidity News 2010
Rotronic presents the new issue of its customer magazine 'Humidity News'. The 16-page brochure offers an interesting mix of international application reports and information on the latest products for measuring temperature and humidity. Among other articles,...
Press Releases
HIV-1 patients with an undetectable viral load can switch to VIRAMUNE® regardless of their CD4 count
Boehringer Ingelheim announced today that the European Commission has approved an update to the Summary of Product Characteristics (SmPC) for VIRAMUNE® (nevirapine) in the treatment of patients with HIV. The label change means that HIV -1...
Press Releases
Ensure FDA and EMA Compliance with Continuous Monitoring Records, 24/7 Alarming and Automated Reporting
ow to ensure your regulated environments and equipment are always in full compliance with FDA and EMA regulations? An automated monitoring and alarming system providing high accuracy fail-safe data is the answer. Investment in industry-leading instrumentation...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read